MedPath

Evaluation of tissue-engineered hair follicles in hair loss

Phase 1
Conditions
Androgenetic alopecia.
Androgenic alopecia
Registration Number
IRCT20080901001159N32
Lead Sponsor
Skin and Stem cell Research Center of Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
5
Inclusion Criteria

Hamilton scaling male pattern hair loss more than 3

Exclusion Criteria

History of malignancy
Known chronic disease
Systemic or local active infection
Histroy of cell therapy or hair transplantation
Viral infections (HBV,HIV ? HCV)
History of allergies and sensitivities
Patients with contact dermatitis, psoriasis, itching or dry skin
Mood disorders, depression, or neuropathy
Anti coagulative drugs
Hypo/ hyperthyroidism

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety. Timepoint: Intervention start date up to 6 months. Method of measurement: Medical history and physical examination.
Secondary Outcome Measures
NameTimeMethod
umber of formed hairs. Timepoint: Before intervention, every 4 weeks up to 6 months. Method of measurement: Trichogram.;Thickness of formed hairs. Timepoint: Before intervention, every 4 weeks up to 6 months. Method of measurement: Trichogram.;Density of formed hairs. Timepoint: Before intervention, every 4 weeks up to 6 months. Method of measurement: Trichogram.
© Copyright 2025. All Rights Reserved by MedPath